Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers
Table 1
Demographic data and disease characteristics.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Demographic data and disease characteristics.